ProQR - PRQR Net Assets per Single Share

Graphic logo of ProQR Therapeutics (PRQR)

The market dynamics of ProQR Therapeutics N.V. (PRQR) reflect the execution of the company's strategy to forge alliances with industry behemoths to combat hereditary pathologies. Demand for RNA editing innovations remains colossal, providing significant growth potential. The current indicator stands at 0.64, while ProQR Therapeutics N.V. (PRQR) generates revenue through licensing fees, aiding the treatment of severe liver and visual organ impairments.

ProQR Therapeutics N.V. (PRQR) Equity per Share: for the period 07/04/2022 - 10/27/2026

ProQR - analytical breakdowns and key metrics (PRQR)

- price and consensus price forecast:
Price Chart ProQR Therapeutics NV|PRQR - Analyst Target Range
- market capitalization data:
Market Value ProQR Therapeutics|PRQR - Value Adjusted for Debt and Cash
- book capitalization data:
Book Value per Share ProQR Therapeutics N.V.|PRQR - Accounting Capitalization|Market Value to Book Value Ratio proqr.com|PRQR - Total Business Assets
- debt and liquidity data:
Total Debt to Capital ProQR Therapeutics N.V.|PRQR - Long-Term Debt to Capital|Short-Term Debt to Equity ProQR Therapeutics NV|PRQR - Company Aggregate Indebtedness|Debt to Book Capitalization Ratio ProQR Therapeutics
Fundamental company valuation:PRQR proqr.com
Manufactured products of ProQR Therapeutics NV

Book value per share is defined as the ratio of equity minus preferred obligations to the number of common shares, allowing for an assessment of the business's intrinsic value independent of market fluctuations. For ProQR Therapeutics (PRQR), which invests in a high-paid staff of RNA medicine experts, the book value per share serves as an indicator of capital management efficiency when financing costly research.

Competitor analysis for ProQR Therapeutics N.V.

Net Assets per Single Share TEM|QGEN: Book Value of One Share|Net Assets per Single Share Ionis Pharmaceuticals IONS|repligen.com (RGEN) - Accounting Value of a Share|Book Value per Share Avidity Biosciences, Inc. (RNA)|Equity per Share CRSP|Net Assets per Single Share Sema4 WGS|Equity per Share Ultragenyx Corp (RARE)|Book Value per Share BEAM (Beam Therapeutics Inc.)|sarepta.com - Book Value per Share|Net Assets per Single Share Twist Bioscience, Inc.|TXG: Share Book Value|Net Assets per Single Share Intellia NTLA|STOK (Stoke Corp) - Accounting Value of a Share|Net Assets per Single Share BLFS (BioLife Solutions, Inc.)|Net Asset Value per Share WVE|MAZE: Net Assets per Single Share|Book Value of One Share SION (Sionna Therapeutics, Inc.)|Net Assets per Single Share Prime Medicine Corp|TSHA - Accounting Value of a Share|Accounting Value per Share uniQure N.V. (QURE)|meiragtx.com (MGTX) - Accounting Value of a Share|RGNX - Accounting Value per Share|Solid Biosciences Inc (SLDB) - Book Price of a Share|OCGN - Book Value per Share|Accounting Value of a Share PacBio Corp|Benitec Biopharma Inc. - Book Value per Share|Net Asset Value per Share DSGN (designtx.com)|Net Assets per Single Share Rocket Pharmaceuticals, Inc.|Accounting Value of a Share 4DMT FDMT|Lexeo - Book Value per Share|KRRO: Book Value per Share|Net Assets per Single Share Editas Medicine, Inc. (EDIT)|silence-therapeutics.com (SLN) - Share Book Value|Book Value per Share CDXS (Codexis Inc)|Net Asset Value per Share Sangamo Therapeutics Inc. (SGMO)|Accounting Value per Share NAUT|Book Value per Share Metagenomi Therapeutics MGX|Accounting Value per Share Precision BioSciences, Inc. (DTIL)|Book Price of a Share Generation Bio Co GBIO|Book Value per Share BOLD (Boundless Bio)|XCUR - Net Assets per Share|IMNN (imunon.com) - Book Value per Share|PHIO (Phio Pharmaceuticals Corp.) - Accounting Value per Share|MBIO: Net Assets per Single Share|Net Assets per Share TransCode (RNAZ)|Bionano Genomics, Inc. (BNGO) - Accounting Value per Share|Accounting Value of a Share APDN (Applied DNA Sciences Inc)|BLUE - Net Assets per Single Share|IPA - Equity per Share|Accounting Value per Share OMGA (Omega Therapeutics)|singulargenomics.com (OMIC) - Net Assets per Share|Regulus Therapeutics Inc. (RGLS) - Accounting Value per Share|Net Assets per Single Share Syros Pharmaceuticals Inc.|TBIO: Accounting Value per Share|Net Assets per Share TCON|UBX - Net Assets per Single Share